Literature DB >> 35728162

The persistence of neutralising antibodies up to 11 months after SARS CoV-2 infection in the southern region of New Zealand.

Reuben McGregor1, Alyson Craigie2, Susan Jack3, Arlo Upton4, Nicole J Moreland5, James E Ussher6.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35728162

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


× No keyword cloud information.
  1 in total

1.  Immunogenicity of BNT162b2 COVID-19 vaccine in New Zealand adults.

Authors:  Frances H Priddy; Michael Williams; Simon Carson; Brittany Lavender; Julia Mathieson; Chris Frampton; Nicole J Moreland; Reuben McGregor; Georgia Williams; Maia Brewerton; Katie Gell; James Ussher; Graham Le Gros
Journal:  Vaccine       Date:  2022-07-12       Impact factor: 4.169

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.